View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
January 4, 1987

BOTTOM, TOP END MICROVAXES, FOUR-CPU VAX IN DEC’s 1987

By CBR Staff Writer

Having established itself as a safe and viable alternate supplier to IBM – one of the quotes of 1986 was it is irresponsible to ignore the Digital alternative (CI No 534) – DEC faces 1987 with the pressing requirement to maintain and extend the lead its product line has won over IBM, and observers are looking for the company to add products right through its line to answer the superficial threat of the IBM 9370s. In the MicroVAX world, the company is expected to come out shortly with a bottom end answer to the Personal Computer in applications like factory automation. Coming in below the MicroVAX II, the new machine is expected to run the VAXeln real-time operating system for factory and laboratory data acquisition applications (incidentally adding one more applications area where the PDP-11 is rendered redundant). The DEC answer to the IBM 9370s is expected to be a line of MicroVAXes offering two to four times the performance of the II, to outperform the 9377 at the top end and rub in the message that the IBM machines are nothing more than very old architecture in snazzy new clothing. These machines are expected out by mid-year. And by the end of the year, the VAX 8000 line is expected to start trampling around the foothills of the Sierras with a four-processor machine that is expected to deliver 30 MIPS. The key to this machine will be a true multiprocessor implementation of VMS rather than the present master-slave attached processor version.

Topics in this article :
Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how New Statesman Media Group may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
THANK YOU